Raymond James Upgrades Regeneron Pharma (REGN) to Market Perform, 'limited remaining clinical downside catalysts during 2023'
Tweet Send to a Friend
(Updated - March 23, 2023 10:29 AM EDT)
Raymond James analyst Dane Leone upgraded Regeneron Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Dane Leone upgraded Regeneron Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
